MHRA Issues Guidance on New Medical Device Regulation in UK

As a result of Brexit, the In Vitro Diagnostic Medical Device Regulations (IVDR) will not apply to Great Britain (England, Wales and Scotland). Unlike Great Britain, the IVDR will apply in Northern Ireland from 26 May 2022.

Guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA) on December 31^st 2020, clarifies the regulation of medical devices (inclusive of in vitro diagnostic medical devices and active implantable medical devices) in Great Britain.

Of note for medical device manufacturers entering the Great Britain market, is the grace period for registering devices with the MHRA; grace period dates span from May 2021 to January 2022 for different classes of devices. CE marking will continue to be recognized in Great Britain until June 2023, from July 1^st 2023, a UKCA (UK Conformity Assessed) mark will be required. UK Approved Bodies, designated by the MHRA will conduct UKCA mark assessments; device manufacturers will also need to appoint a single UK Responsible Person who will be responsible for the product in Great Britain.

Veranex (formerly Boston Healthcare Associates) continues to track implications of Brexit and IVDR on the regulation of medical devices, ensuring manufacturers are equipped to factor in additional time and resources needed to comply with differing requirements between the EU and Great Britain.  If your plans include an EU medical devic